Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA
Links shared publicly online about this topic.
- 801total visits
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA
View full resource at medicalnewstoday.com
Tags: Addiction, Substance Addiction, Drug, FDA, Psychology
Most Recently Shared on October 15, 2010 at 1:05 am By:
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA http://mnt.to/3LfM #psychology
Also Shared By:
Data On VIVITROL(R), The New FDA-Approved Medication For Prevention Of Relapse To Opioid Dependence, Published In The Lancet
medicalnewstoday.com — “Alkermes, Inc. (NASDAQ: ALKS) today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been p” View full resource at medicalnewstoday.com
Most Recently Shared on April 28, 2011 at 12:05 pm By:
Data On VIVITROL(R), The New FDA-Approved Medication For Prevention Of Relapse To Opioid Dependence, Published In The ... http://mnt.to/3V8G
Alkermes Announces FDA Approval Of VIVITROL For Prevention Of Relapse To Opioid Dependence - QualityPoint Technologies
qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) has approved VIVITROL (naltrexone for extended-release injectable suspension) for the prevention of relapse to opioid dependence, following opioid detoxification. VIVITROL is now the first and only non-narcotic, non-addictive, once-monthly medication approved for the treatment of opioid dependence. VIVITROL was approved by the FDA in 2006 for the treatment of alcohol dependence and should be used as part of ” View full resource at qualitypointtech.net
Most Recently Shared on October 16, 2010 at 10:49 pm By:
Alkermes Announces FDA Approval Of VIVITROL® For Prevention Of Relapse To Opioid Dependence: Alkermes, Inc. (NASD... http://bit.ly/bCwk5v
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA - QualityPoint Technologies
qualitypointtech.net — “Vivitrol (Naltrexone) in injection form has been approved by the FDA (Food and Drug Administration) for opioid dependent patients - individuals addicted to opioids - who have received detoxification therapy. The injection is administered into the muscle (intramuscularly) once per month. Naltrexone is an opioid receptor antagonist - it blocks the brain's opioid receptors. Examples of opioids include heroin, morphine, codeine, and thebaine...” View full resource at qualitypointtech.net
Most Recently Shared on October 15, 2010 at 9:49 am By:
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA: Vivitrol (Naltrexone) in injection... http://bit.ly/aspHvY
FDA Approves Vivitrol to Treat Opioid-dependent Patients
drugs.com — “Vivitrol (naltrexone) is used to treat alcohol dependence and opioid dependence. Includes Vivitrol side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 13, 2010 at 11:08 pm By:
FDA Approves Vivitrol to Treat Opioid-dependent Patients: ROCKVILLE, Md., Oct. 12, 2010--The U.S. Food and Dr... http://bit.ly/98nTjo #drug
FDA Approves Injectable Drug To Treat Opioid-Dependent Patients
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.Vivitrol is an extended-” View full resource at medicalnewstoday.com
Most Recently Shared on October 13, 2010 at 4:21 pm By:
FDA Approves Injectable Drug To Treat Opioid-Dependent Patients http://mnt.to/3L8Z #alcohol #addiction
Vivitrol approved for opioid dependence - MPR
empr.com — “The FDA has approved Vivitrol (naltrexone for injection, from Alkermes) to treat and prevent relapse after patients with opioid dependence have undergone detoxification treatment.” View full resource at empr.com
Most Recently Shared on October 13, 2010 at 3:43 pm By:
MPR News: Vivitrol approved for opioid dependence: The FDA has approved Vivitrol (naltrexone extended-release inje... http://bit.ly/9cWdEE
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence - QualityPoint Technologies
qualitypointtech.net — “Alkermes, Inc. (NASDAQ: ALKS) announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence...” View full resource at qualitypointtech.net
Most Recently Shared on September 19, 2010 at 2:01 pm By:
Alkermes Announces FDA Advisory Committee Recommends Approval Of VIVITROL(R) For Opioid Dependence: Alkermes, Inc.... http://bit.ly/aQwbNM
FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence
news-medical.net — “Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL® (naltrexone for extended-release injectable suspension) should be approved for the treatment of opioid dependence.” View full resource at news-medical.net
Most Recently Shared on September 17, 2010 at 4:54 am By:
FDA Advisory Committee recommends approval of Alkermes' VIVITROL for opioid dependence: Alkermes, Inc. today annou... http://bit.ly/aga8bQ
Alkermes to Seek FDA Approval of Anti-Addiction Drug | Xconomy
xconomy.com — “Cambridge,MA-based biotech Alkermes said this morning that its long-acting naltrexone injection (Vivitrol) was more effective in treating opioid drug dependence” View full resource at xconomy.com
Most Recently Shared on November 17, 2009 at 12:53 pm By:
RT @CenterWatch: Alkermes to file for approval of Vivitrol for opioid addiction in the first half of 2010. http://ow.ly/CRAQ
Advertisement




medical_tweets
@medical_tweets
Injectable Vivitrol (Naltrexone) Approved For Opioid Dependent Patients By FDA Vivitrol (Naltrexone) in injection form .. http://dld.bz/z9S8
1 year ago...